Literature DB >> 1997414

Effects of Bordetella bronchiseptica dermonecrotic toxin on the structure and function of osteoblastic clone MC3T3-e1 cells.

Y Horiguchi1, T Nakai, K Kume.   

Abstract

The effects of Bordetella bronchiseptica dermonecrotic toxin on the structure and function of a clonal osteoblastic cell line, MC3T3-E1, were investigated. The toxin induced a morphological change in the cells from a spindle shape to a spherical form with many blebs. The toxin-treated cells were viable and grew to form confluent cell layers composed of irregularly shaped cells and multinuclear cells. The toxin inhibited elevation of alkaline phosphatase activity in the cells in a dose-dependent manner at concentrations from 10 pg to 10 ng/ml. The accumulation of type I collagen in the cells was also reduced by the toxin. Since high alkaline phosphatase activity and accumulation of collagen are closely linked to differentiation of the cells into osteoblasts, it is considered likely that B. bronchiseptica dermonecrotic toxin impairs the ability of the cells to differentiate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997414      PMCID: PMC258375          DOI: 10.1128/iai.59.3.1112-1116.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The quantitative histochemistry of brain. II. Enzyme measurements.

Authors:  O H LOWRY; N R ROBERTS; M L WU; W S HIXON; E J CRAWFORD
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

2.  Electron microscopic evaluation of bone cells in pigs with experimentally induced Bordetella rhinitis (turbinate osteoporosis).

Authors:  A W Fetter; W P Switzer; C C Capen
Journal:  Am J Vet Res       Date:  1975-01       Impact factor: 1.156

3.  Prostaglandin E1 and F2 alpha stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro.

Authors:  Y Hakeda; T Hotta; N Kurihara; E Ikeda; N Maeda; Y Yagyu; M Kumegawa
Journal:  Endocrinology       Date:  1987-12       Impact factor: 4.736

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Simplified procedure for purification of Bordetella bronchiseptica dermonecrotic toxin.

Authors:  Y Horiguchi; T Nakai; K Kume
Journal:  FEMS Microbiol Lett       Date:  1990-01-01       Impact factor: 2.742

7.  Stimulation of intestinal adenyl cyclase by cholera toxin.

Authors:  G W Sharp; S Hynie
Journal:  Nature       Date:  1971-01-22       Impact factor: 49.962

8.  Lienotoxicity of Bordetella pertussis in mice.

Authors:  T Iida; T Okonogi
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

9.  Ultrastructural evaluation of bone cells in pigs with experimental turbinate osteoporosis (atrophic rhinitis).

Authors:  A W Fetter; C C Capen
Journal:  Lab Invest       Date:  1971-05       Impact factor: 5.662

10.  Contractile action of heat-labile toxin of Bordetella parapertussis on aortic smooth muscles of pigs.

Authors:  M Endoh; M Nagai; Y Nakase
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

View more
  20 in total

1.  In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin.

Authors:  Minako Masuda; Masayoshi Minami; Hiroaki Shime; Takeshi Matsuzawa; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Bordetella bronchiseptica dermonecrotizing toxin induces reorganization of actin stress fibers through deamidation of Gln-63 of the GTP-binding protein Rho.

Authors:  Y Horiguchi; N Inoue; M Masuda; T Kashimoto; J Katahira; N Sugimoto; M Matsuda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp.

Authors:  G D Pullinger; T E Adams; P B Mullan; T I Garrod; A J Lax
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 5.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Stimulation of DNA synthesis in osteoblast-like MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin.

Authors:  Y Horiguchi; N Sugimoto; M Matsuda
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine.

Authors:  Susan L Brockmeier; Karen B Register; Tibor Magyar; Alistair J Lax; Gillian D Pullinger; Robert A Kunkle
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

9.  Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin.

Authors:  M Masuda; L Betancourt; T Matsuzawa; T Kashimoto; T Takao; Y Shimonishi; Y Horiguchi
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

10.  Experimental model of atrophic rhinitis in gnotobiotic pigs.

Authors:  M R Ackermann; R B Rimler; J R Thurston
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.